List of Tables
Table 1. Global Subcutaneous Drug Delivery Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Subcutaneous Drug Delivery Devices Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Subcutaneous Drug Delivery Devices Market Competitive Situation by Manufacturers in 2024
Table 4. Global Subcutaneous Drug Delivery Devices Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Subcutaneous Drug Delivery Devices Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Subcutaneous Drug Delivery Devices Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Subcutaneous Drug Delivery Devices Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Subcutaneous Drug Delivery Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Subcutaneous Drug Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Subcutaneous Drug Delivery Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Subcutaneous Drug Delivery Devices, Product Type & Application
Table 12. Global Key Manufacturers of Subcutaneous Drug Delivery Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Subcutaneous Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Drug Delivery Devices as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Subcutaneous Drug Delivery Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Subcutaneous Drug Delivery Devices Sales by Region (2020-2025) & (K Units)
Table 18. Global Subcutaneous Drug Delivery Devices Sales Market Share by Region (2020-2025)
Table 19. Global Subcutaneous Drug Delivery Devices Sales by Region (2026-2031) & (K Units)
Table 20. Global Subcutaneous Drug Delivery Devices Sales Market Share by Region (2026-2031)
Table 21. Global Subcutaneous Drug Delivery Devices Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Region (2020-2025)
Table 23. Global Subcutaneous Drug Delivery Devices Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Region (2026-2031)
Table 25. North America Subcutaneous Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Subcutaneous Drug Delivery Devices Sales by Country (2020-2025) & (K Units)
Table 27. North America Subcutaneous Drug Delivery Devices Sales by Country (2026-2031) & (K Units)
Table 28. North America Subcutaneous Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Subcutaneous Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Subcutaneous Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Subcutaneous Drug Delivery Devices Sales by Country (2020-2025) & (K Units)
Table 32. Europe Subcutaneous Drug Delivery Devices Sales by Country (2026-2031) & (K Units)
Table 33. Europe Subcutaneous Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Subcutaneous Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Subcutaneous Drug Delivery Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Subcutaneous Drug Delivery Devices Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Subcutaneous Drug Delivery Devices Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Subcutaneous Drug Delivery Devices Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Subcutaneous Drug Delivery Devices Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Subcutaneous Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Subcutaneous Drug Delivery Devices Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Subcutaneous Drug Delivery Devices Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Subcutaneous Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Subcutaneous Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Subcutaneous Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Subcutaneous Drug Delivery Devices Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Subcutaneous Drug Delivery Devices Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Subcutaneous Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Subcutaneous Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Subcutaneous Drug Delivery Devices Sales (K Units) by Type (2020-2025)
Table 51. Global Subcutaneous Drug Delivery Devices Sales (K Units) by Type (2026-2031)
Table 52. Global Subcutaneous Drug Delivery Devices Sales Market Share by Type (2020-2025)
Table 53. Global Subcutaneous Drug Delivery Devices Sales Market Share by Type (2026-2031)
Table 54. Global Subcutaneous Drug Delivery Devices Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Subcutaneous Drug Delivery Devices Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Type (2020-2025)
Table 57. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Type (2026-2031)
Table 58. Global Subcutaneous Drug Delivery Devices Price (USD/Unit) by Type (2020-2025)
Table 59. Global Subcutaneous Drug Delivery Devices Price (USD/Unit) by Type (2026-2031)
Table 60. Global Subcutaneous Drug Delivery Devices Sales (K Units) by Application (2020-2025)
Table 61. Global Subcutaneous Drug Delivery Devices Sales (K Units) by Application (2026-2031)
Table 62. Global Subcutaneous Drug Delivery Devices Sales Market Share by Application (2020-2025)
Table 63. Global Subcutaneous Drug Delivery Devices Sales Market Share by Application (2026-2031)
Table 64. Global Subcutaneous Drug Delivery Devices Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Subcutaneous Drug Delivery Devices Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Application (2020-2025)
Table 67. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Application (2026-2031)
Table 68. Global Subcutaneous Drug Delivery Devices Price (USD/Unit) by Application (2020-2025)
Table 69. Global Subcutaneous Drug Delivery Devices Price (USD/Unit) by Application (2026-2031)
Table 70. BD Company Information
Table 71. BD Description and Business Overview
Table 72. BD Subcutaneous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. BD Subcutaneous Drug Delivery Devices Product
Table 74. BD Recent Developments/Updates
Table 75. Insulet Corporation Company Information
Table 76. Insulet Corporation Description and Business Overview
Table 77. Insulet Corporation Subcutaneous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Insulet Corporation Subcutaneous Drug Delivery Devices Product
Table 79. Insulet Corporation Recent Developments/Updates
Table 80. Enable Injections Company Information
Table 81. Enable Injections Description and Business Overview
Table 82. Enable Injections Subcutaneous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Enable Injections Subcutaneous Drug Delivery Devices Product
Table 84. Enable Injections Recent Developments/Updates
Table 85. West Pharmaceutical Services, Inc Company Information
Table 86. West Pharmaceutical Services, Inc Description and Business Overview
Table 87. West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Product
Table 89. West Pharmaceutical Services, Inc Recent Developments/Updates
Table 90. Ypsomed AG Company Information
Table 91. Ypsomed AG Description and Business Overview
Table 92. Ypsomed AG Subcutaneous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Ypsomed AG Subcutaneous Drug Delivery Devices Product
Table 94. Ypsomed AG Recent Developments/Updates
Table 95. Elcam Medical Company Information
Table 96. Elcam Medical Description and Business Overview
Table 97. Elcam Medical Subcutaneous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Elcam Medical Subcutaneous Drug Delivery Devices Product
Table 99. Elcam Medical Recent Developments/Updates
Table 100. Amgen Company Information
Table 101. Amgen Description and Business Overview
Table 102. Amgen Subcutaneous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Amgen Subcutaneous Drug Delivery Devices Product
Table 104. Amgen Recent Developments/Updates
Table 105. Wilhelm Haselmeier Company Information
Table 106. Wilhelm Haselmeier Description and Business Overview
Table 107. Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Product
Table 109. Wilhelm Haselmeier Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Subcutaneous Drug Delivery Devices Distributors List
Table 113. Subcutaneous Drug Delivery Devices Customers List
Table 114. Subcutaneous Drug Delivery Devices Market Trends
Table 115. Subcutaneous Drug Delivery Devices Market Drivers
Table 116. Subcutaneous Drug Delivery Devices Market Challenges
Table 117. Subcutaneous Drug Delivery Devices Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Subcutaneous Drug Delivery Devices
Figure 2. Global Subcutaneous Drug Delivery Devices Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Subcutaneous Drug Delivery Devices Market Share by Type: 2024 & 2031
Figure 4. Prefilled Injectable Product Picture
Figure 5. Filled Injectable Product Picture
Figure 6. Global Subcutaneous Drug Delivery Devices Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Subcutaneous Drug Delivery Devices Market Share by Application: 2024 & 2031
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Subcutaneous Drug Delivery Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Subcutaneous Drug Delivery Devices Market Size (2020-2031) & (US$ Million)
Figure 13. Global Subcutaneous Drug Delivery Devices Sales (2020-2031) & (K Units)
Figure 14. Global Subcutaneous Drug Delivery Devices Average Price (USD/Unit) & (2020-2031)
Figure 15. Subcutaneous Drug Delivery Devices Report Years Considered
Figure 16. Subcutaneous Drug Delivery Devices Sales Share by Manufacturers in 2024
Figure 17. Global Subcutaneous Drug Delivery Devices Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Subcutaneous Drug Delivery Devices Players: Market Share by Revenue in Subcutaneous Drug Delivery Devices in 2024
Figure 19. Subcutaneous Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Subcutaneous Drug Delivery Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Subcutaneous Drug Delivery Devices Sales Market Share by Country (2020-2031)
Figure 22. North America Subcutaneous Drug Delivery Devices Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Subcutaneous Drug Delivery Devices Sales Market Share by Country (2020-2031)
Figure 26. Europe Subcutaneous Drug Delivery Devices Revenue Market Share by Country (2020-2031)
Figure 27. Germany Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Subcutaneous Drug Delivery Devices Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Subcutaneous Drug Delivery Devices Revenue Market Share by Region (2020-2031)
Figure 34. China Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Subcutaneous Drug Delivery Devices Sales Market Share by Country (2020-2031)
Figure 45. Latin America Subcutaneous Drug Delivery Devices Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Subcutaneous Drug Delivery Devices Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Subcutaneous Drug Delivery Devices Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Subcutaneous Drug Delivery Devices by Type (2020-2031)
Figure 55. Global Revenue Market Share of Subcutaneous Drug Delivery Devices by Type (2020-2031)
Figure 56. Global Subcutaneous Drug Delivery Devices Price (USD/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Subcutaneous Drug Delivery Devices by Application (2020-2031)
Figure 58. Global Revenue Market Share of Subcutaneous Drug Delivery Devices by Application (2020-2031)
Figure 59. Global Subcutaneous Drug Delivery Devices Price (USD/Unit) by Application (2020-2031)
Figure 60. Subcutaneous Drug Delivery Devices Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed